zil pharma enterprises private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 18 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 2 bids — R S ENTERPRISES appeared in 2 of them.
ZIL PHARMA ENTERPRISES PRIVATE LIMITED
ZIL PHARMA ENTERPRISES PRIVATE LIMITED
Financial Details
Registered Office
Floor Basmen, Plot -41, Merchant Chamber Vitthaldas Thackarsey Marg, ChurchgateNA-Mumbai-Maharashtra-400020-India
Industry Classification
Trading
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
3
Contract Value
₹1.60 Cr
L1 Bids
1
Recent Win Rate
0.0%
Performance Analytics
Zil Pharma Enterprises: Government Tender Performance Analysis
Zil Pharma Enterprises Private Limited is emerging as a player in the Indian government tender ecosystem, actively participating in 3 tenders between May 2022 and March 2025. This business analysis report provides a comprehensive overview of their early tender performance, technical qualification rate, and evolving procurement strategy.
Executive Summary
Zil Pharma Enterprises Private Limited has made initial strides in government procurement, demonstrating a 33.3% win rate based on 3 bids submitted between May 2022 and March 2025. This includes securing 1 L1 position, highlighting their competitive pricing in specific tenders. The company’s financial health is assessed as 'Satisfactory' with a score of 62.1/100 by TenderAI, based on win rate, contract value, bid efficiency, and growth potential. Their market positioning indicates a strong focus on select government departments, particularly the Department of Atomic Energy and the Urban Development and Urban Housing Department Gujarat.
As a pharma sector provider, Zil Pharma Enterprises is navigating the competitive landscape of Indian government contracts. With early successes and identified areas for improvement, the company is poised for growth in the public sector procurement space. Key performance metrics include a 33.3% qualification rate alongside a 100.0% qualified-to-win ratio, demonstrating their ability to convert qualified bids into successful contracts.
Financial Performance Analysis
Yearly Trends
A review of yearly performance reveals a recent uptick in activity. In FY 2023-24, Zil Pharma Enterprises participated in 1 tender, achieving a 100.0% win rate and securing a contract value of ₹30,61,743. In contrast, FY 2024-25 shows 2 bids with 0 wins, with a contract value of ₹1,29,16,723.